Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Preface - p. xxiii 8. SECTION I: RADIATION ONCOLOGY - p. xxiv 9. Adaptative Radiation Therapy - p. 1 10. Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders - p. 15 11. SECTION II: SURGICAL ONCOLOGY - p. 24 12. Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors - p. 25 13. Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors - p. 35 14. Contemporary Approaches to Adrenocortical Carcinoma - p. 43 15. SECTION III: MEDICAL ONCOLOGY - p. 51 16. State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer - p. 53 17. Integration of Early Palliative Care in Personalized Cancer Care - p. 65 18. Treatment Advances in Small Cell Lung Cancer - p. 73 19. SECTION IV: GYNECOLOGIC ONCOLOGY - p. 80 20. Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer - p. 81 21. Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer - p. 95 22. SECTION V: PEDIATRIC ONCOLOGY - p. 105 23. Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions - p. 107 24. Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations - p. 117 25. Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors - p. 127 26. SECTION VI: NEURO-ONCOLOGY, RIMAS LUKAS - p. 133 27. Treatment of Isocitrate Dehydrogenase-Mutant Gliomas - p. 135 28. Exosomes in Glioma: Diagnostic and Therapeutic Potentials - p. 151 29. Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas - p. 163 30. SECTION VII: HEMATOLOGICAL ONCOLOGY - p. 175 31. Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia? - p. 177 32. Current and Future Approaches for the Treatment of Plasma Cell Leukemia - p. 189 33. Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why - p. 201 34. SECTION VIII: URO-ONCOLOGY - p. 211 35. Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer - p. 213 36. Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions - p. 223 37. Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer - p. 235 38. SECTION IX: GASTROINTESTINAL ONCOLOGY - p. 246 39. The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies - p. 247 40. How I Treat Advanced Biliary Cancer - p. 257 41. Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies - p. 267
Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Preface - p. xxiii 8. SECTION I: RADIATION ONCOLOGY - p. xxiv 9. Adaptative Radiation Therapy - p. 1 10. Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders - p. 15 11. SECTION II: SURGICAL ONCOLOGY - p. 24 12. Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors - p. 25 13. Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors - p. 35 14. Contemporary Approaches to Adrenocortical Carcinoma - p. 43 15. SECTION III: MEDICAL ONCOLOGY - p. 51 16. State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer - p. 53 17. Integration of Early Palliative Care in Personalized Cancer Care - p. 65 18. Treatment Advances in Small Cell Lung Cancer - p. 73 19. SECTION IV: GYNECOLOGIC ONCOLOGY - p. 80 20. Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer - p. 81 21. Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer - p. 95 22. SECTION V: PEDIATRIC ONCOLOGY - p. 105 23. Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions - p. 107 24. Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations - p. 117 25. Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors - p. 127 26. SECTION VI: NEURO-ONCOLOGY, RIMAS LUKAS - p. 133 27. Treatment of Isocitrate Dehydrogenase-Mutant Gliomas - p. 135 28. Exosomes in Glioma: Diagnostic and Therapeutic Potentials - p. 151 29. Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas - p. 163 30. SECTION VII: HEMATOLOGICAL ONCOLOGY - p. 175 31. Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia? - p. 177 32. Current and Future Approaches for the Treatment of Plasma Cell Leukemia - p. 189 33. Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why - p. 201 34. SECTION VIII: URO-ONCOLOGY - p. 211 35. Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer - p. 213 36. Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions - p. 223 37. Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer - p. 235 38. SECTION IX: GASTROINTESTINAL ONCOLOGY - p. 246 39. The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies - p. 247 40. How I Treat Advanced Biliary Cancer - p. 257 41. Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies - p. 267
